Position
Fidelity in Aurinia Pharmaceuticals Inc.
Back to the book · All holders of AUPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $685.4K$14.82 → $16.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 268.3K | $4.28M | — | — | — | 0.0% |
| Q1 2026 | 318.8K | $4.72M | $14.82 | −$303.2K | $748.1K | 0.0% |
| Q2 2026 | 372.5K | $6.32M | $16.97 | $685.4K | $911.3K | 0.0% |